PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of May 21, 2026, PRCT trades at $28.30 with a market cap of $1.48B and a P/E ratio of -16.03. PRCT moved +8.57% today. Year to date, PRCT is -15.13%; over the trailing twelve months it is -52.50%. Its 52-week range spans $19.35 to $103.81. Analyst consensus is buy with an average price target of $36.50. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes PRCT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $28.30 |
| Market Cap | $1.48B |
| P/E Ratio | -16.03 |
| EPS | $-1.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $103.81 |
| 52-Week Low | $19.35 |
| Volume | 55 |
| Avg Volume | 0 |
| Revenue (TTM) | $308.05M |
| Net Income | $-95.57M |
| Gross Margin | 63.70% |
11 analysts cover PRCT: 0 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $36.50.